跳到正文
研踪PaperTrail

YOUR RESEARCH, IN SIGHT

让下一篇重要论文,不再错过。

覆盖计算机全学科,以 AI 为快捷入口。关注方向、作者和关键词,把发现变成持续的研究积累。

采集已暂停
正在读取账号与研究记录…

全站更新概况

+0新增论文
+0其中 AI 相关
+0已有论文修订
+0新增 AI 导读

arXiv 最近完成扫描:等待完成 · 全站最近入库:2026-11-02 00:39各信源进度 →

统计口径与数据新鲜度

统计 2026-11-03 22:32 — 2026-11-04 22:32(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:尚未完成最近发现新增版本:2026-11-02 00:39库内论文最新更新时间:2026-10-30 01:59

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

8,677 已收录论文7,675 AI 相关1,866 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。

找到 1 篇论文 · 按版本更新时间排序等待首次采集
新论文 · v1arXiv:2610.37074

Systematic Morphometric Brain Autoencoding for Representation Learning in Neurodegenerative Diseases

Nuria Balbás-Esteban, Albert Belenguer-Llorens, Elaheh Moradi, Jussi Tohka, Vanessa Gómez-Verdejo, Carlos Sevilla-Salcedo

Early identification of neurodegenerative disorders using structural T1-weighted MRI is essential for timely clinical intervention, yet supervised deep learning models often struggle to generalize due to limited annotations and scanner-induced distribution shift. Self-supervised learning offers a promising alternative; however, existing approaches are largely adapted from natural image paradigms, relying on contrastive objectives or generic masked reconstruction with voxel-wise losses, which may not fully capture the distributed morphometric patterns associated with neurodegeneration. We introduce SYMBA (SYstematic Morphometric Brain Autoencoding), a self-supervised pretraining framework specifically designed for structural brain MRI. SYMBA integrates anatomically constrained masking, a multi-scale structural similarity (MS-SSIM) reconstruction objective, and a progressive curriculum that transitions from local anatomical detail to global brain morphology. These components explicitly incorporate neuroanatomical structure into the self-supervised objective rather than relying on generic image priors. Pretrained on 6,953 T1-weighted MRI scans from nine heterogeneous cohorts, SYMBA is evaluated using frozen linear probing on two independent unseen datasets, enabling a strict assessment of out-of-distribution generalization. Across multiple clinical tasks, SYMBA consistently outperforms recent neuroimaging foundation models, achieving 0.930 AUROC for Alzheimer's disease classification, 0.772 for mild cognitive impairment conversion prediction, and strong performance in amyloid status prediction. In low-label regimes, SYMBA demonstrates high sample efficiency, reaching approximately 0.90 AUROC for AD/CN classification using only six labeled subjects.

尚无 AI 解读,展示原文摘要

cs.CV · cs.LG
arXiv ↗PDF ↗